Retension Pharmaceuticals, Inc. Common Stock（RTSN）價格預測

$10.720

-0.809 (-7.55%)收盤時

價格預測

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

在 App 中開啟以解鎖更長週期的預測。

Loading chart…

該買進 Retension Pharmaceuticals, Inc. Common Stock 股票嗎？

Retension Pharmaceuticals may not be a good buy right now due to its current price of $11.44, which is significantly below the analyst's target of $55, but the recent 5-day decline of 19.66% raises concerns about short-term performance. The company has reported negative net income in the last four quarters, with a loss of $4,170,589 in Q2 2026, indicating ongoing financial struggles.

RTSN 股價於 Thursday 收在 $10.72，此前下跌 -7.55%

Retension Pharmaceuticals, Inc. Common Stock (RTSN) last closed at $11.04, gaining +2.99%. These facts feed the 1-day and 1-week RTSN price prediction above.

預測驅動因素

Retension Pharmaceuticals, Inc. Common Stock（RTSN）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。

Seasonality

Negative

Bearish

RTSN 季節性分析